Artemisinin antimalarials moderately affect cytochrome P450 enzyme activity in healthy subjects
- 1 June 2007
- journal article
- research article
- Published by Wiley in Fundamental & Clinical Pharmacology
- Vol. 21 (3), 307-316
- https://doi.org/10.1111/j.1472-8206.2007.00471.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Enantiospecific separation and quantitation of mephenytoin and its metabolites nirvanol and 4′-hydroxymephenytoin in human plasma and urine by liquid chromatography/tandem mass spectrometryRapid Communications in Mass Spectrometry, 2006
- Antimalarial Artemisinin Drugs Induce Cytochrome P450 and MDR1 Expression by Activation of Xenosensors Pregnane X Receptor and Constitutive Androstane ReceptorMolecular Pharmacology, 2005
- The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytesToxicology and Applied Pharmacology, 2004
- Identification of an antimalarial synthetic trioxolane drug development candidateNature, 2004
- An interaction between the cytochrome P450 probe substrates chlorzoxazone (CYP2E1) and midazolam (CYP3A)British Journal of Clinical Pharmacology, 2001
- Identification of the human cytochrome P450 enzymes involved in the in vitro metabolism of artemisininBritish Journal of Clinical Pharmacology, 1999
- Multiple dose pharmacokinetics of oral artemisinin and comparison of its efficacy with that of oral artesunate in falciparum malaria patientsTransactions of the Royal Society of Tropical Medicine and Hygiene, 1996
- Simple and reliable CYP1A2 phenotyping by the paraxanthine/caffeine ratio in plasma and in salivaPharmacogenetics, 1994
- Cocktail Strategy: Complications and LimitationsThe Journal of Clinical Pharmacology, 1993
- A ‘cocktail’ strategy to assess in vivo oxidative drug metabolism in humansTrends in Pharmacological Sciences, 1990